[Coronary atherosclerosis lesion features in coronary artery disease patients complicating with metabolic syndrome]
Related Experiment Video
Updated: May 4, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Yang Gao1, Bin Lü1, Zhi-hui Hou1
1Department of Radiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Center for Cardiovascular Diseases, Beijing 100037, China.
Insights
Patients with metabolic syndrome (MetS) have more severe coronary artery calcium deposition and calcified plaque in their arteries, leading to worse obstructive coronary artery disease compared to those without MetS.
Area of Science:
- Cardiology
- Radiology
- Metabolic Diseases
Background:
- Coronary artery disease (CAD) is a leading cause of mortality worldwide.
- Metabolic syndrome (MetS) is a cluster of conditions that increase the risk of heart disease, stroke, and diabetes.
- Understanding the impact of MetS on coronary atherosclerosis is crucial for risk stratification and management.
Purpose of the Study:
- To compare coronary plaque burden, composition, and distribution in patients with and without MetS.
- To assess the degree of coronary artery stenosis in CAD patients with or without MetS.
- To investigate the relationship between MetS and coronary artery calcium deposition.
Main Methods:
- Retrospective analysis of 872 patients diagnosed with CAD via invasive coronary angiography (ICA).
- Coronary computed tomography angiography (CCTA) and ICA were performed within three months.
- Exclusion of patients with prior percutaneous coronary interventions (PCI) or coronary artery bypass grafting (CABG).
Main Results:
- MetS patients exhibited significantly higher coronary artery calcium scores (CACS) compared to non-MetS patients.
- A higher percentage of MetS patients had severe coronary calcium (CACS ≥ 1000) and calcified plaque in middle and distal coronary arteries.
- MetS patients showed a higher prevalence of multi-vessel disease (2-vessel and 3-vessel disease).
Conclusions:
- Metabolic syndrome is associated with more severe coronary artery calcification.
- Patients with MetS have a higher burden of calcified plaque, particularly in the middle and distal coronary arteries.
- MetS is linked to more severe obstructive coronary artery disease.
Purpose:
To compare coronary plaque burden, composition, distribution and the degree of coronary artery stenosis in invasive coronary angiography (ICA) diagnosed coronary artery disease (CAD) patients with or without metabolic syndrome (MetS).
Methods:
From January 2008 to June 2011, consecutive patients underwent both coronary computed tomography angiography (CCTA) and ICA within three months were enrolled. Patients with history of previous percutaneous coronary interventions (PCI) and coronary artery bypass grafting (CABG) were excluded. Plaque characteristics and maximal luminal diameter stenosis were analyzed on a 16-segment basis as suggested by the American Heart Association classification.
Results:
The study population consisted of 872 patients [age (60.2 ± 10.0) years, 72.70% males] including 377 patients with MetS and 495 patients without MetS. The median coronary artery calcium score (CACS) was higher in MetS patients than in non-MetS patients [102 (10, 410) vs. 58 (0, 274) , P < 0.01]. Percentage of patients with no coronary artery calcium was significantly lower in MetS group than in non-MetS group [19.63% (74/377) vs. 30.71% (152/495) , P < 0.01], while percentage of patients with severe coronary calcium (CACS ≥ 1000) were significantly higher in MetS than non-MetS group [8.22% (31/377) vs. 4.65% (23/495) , P = 0.03]. The proportion of patients with 1-vessel disease was lower [23.61% (89/377) vs. 36.77% (182/495), P < 0.01], 2-vessel [29.71% (112/377) vs. 22.83% (113/495), P < 0.05] and 3-vessel disease [35.54% (134/377) vs. 24.44% (121/495) , P < 0.01] were higher in MetS group than in non-MetS group. Calcified plaque of LM and the middle and distal coronary artery were significantly higher in MetS group than in non-MetS group (all P < 0.05) .
Conclusions:
CAD patients with MetS are associated with severer coronary artery calcium deposition and higher percentage of calcified plaque in the middle and distal coronary arteries and severer obstructive coronary vessels.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

